CN Patent

CN115073429A — 一种1，2，4-三嗪-3，5-二酮类化合物的盐型、晶型及其制备方法

Assigned to Shanghai Kunheng Medical Technology Co ltd · Expires 2022-09-20 · 4y expired

What this patent protects

本发明公开了一种1，2，4‑三嗪‑3，5‑二酮类(式I)化合物的盐型、晶型及其制备方法，其在治疗和或药物制备中的用途，所述的用途是治疗与甲状腺激素受体相关的疾病。

USPTO Abstract

本发明公开了一种1，2，4‑三嗪‑3，5‑二酮类(式I)化合物的盐型、晶型及其制备方法，其在治疗和或药物制备中的用途，所述的用途是治疗与甲状腺激素受体相关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN115073429A
Jurisdiction
CN
Classification
—
Expires
2022-09-20
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Kunheng Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.